ENDONOVO THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $19.25 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2017-08-10
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month $19.25M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month |
|---|---|
| 2017-06-30 | $19.25M 10-Q · filed 2017-08-10 |